VYGR Voyager Therapeutics, Inc.
Nasdaq · SEC CIK 1640266 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $334.6K 12 sales by 4 insiders
- Filings on record
- 155 since 2021-11-30, latest 2026-06-11 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Sandrock Alfred | Pres, CEO, Dir | — | $184.4K |
| Swartz Robin | COO, CBO | — | $55.3K |
| Jorgensen Nathan D. | CFO | — | $54.2K |
| Carter Todd Alfred | CSO | — | $40.6K |
| Shiferman Gregory L. | SVP, GC | — | — |
| Ferguson Toby | Chief Medical Off | — | — |
Transactions 110
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-03 17:55 | 2026-04-02 | VYGR | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $3.87 | -11.5K | 472.5K | -2% | -$44.5K |
| 2026-04-03 17:42 | 2026-04-01 | VYGR | Shiferman Gregory L. | SVP, GC | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 | |
| 2026-02-26 | 2026-02-24 | VYGR | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $3.79 | -14.2K | 484.1K | -3% | -$53.8K | |
| 2026-02-26 | 2026-02-24 | VYGR | Carter Todd Alfred | CSO | S - Sale | $3.76 | -4,174 | 145.7K | -3% | -$15.7K | |
| 2026-02-26 | 2026-02-24 | VYGR | Swartz Robin | COO, CBO | S - Sale | $3.77 | -6,458 | 199.7K | -3% | -$24.3K | |
| 2026-02-26 | 2026-02-24 | VYGR | Jorgensen Nathan D. | CFO | S - Sale | $3.77 | -4,668 | 151.4K | -3% | -$17.6K | |
| 2026-02-20 | 2026-02-18 | VYGR | Swartz Robin | COO, CBO | S - Sale | $3.44 | -3,882 | 206.2K | -2% | -$13.4K | |
| 2026-02-20 | 2026-02-18 | VYGR | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $3.41 | -11.7K | 498.3K | -2% | -$40.0K | |
| 2026-02-20 | 2026-02-18 | VYGR | Carter Todd Alfred | CSO | S - Sale | $3.44 | -3,301 | 149.9K | -2% | -$11.4K | |
| 2026-02-11 | 2026-02-10 | VYGR | Carter Todd Alfred | CSO | S - Sale | $3.85 | -3,525 | 153.2K | -2% | -$13.6K | |
| 2026-02-11 | 2026-02-10 | VYGR | Swartz Robin | COO, CBO | S - Sale | $3.85 | -4,569 | 210.1K | -2% | -$17.6K | |
| 2026-02-11 | 2026-02-10 | VYGR | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $3.78 | -12.2K | 510.0K | -2% | -$46.1K | |
| D | 2026-02-10 | 2026-02-06 | VYGR | Jorgensen Nathan D. | CFO | A - Grant | $0.00 | +32.2K | 156.1K | +26% | $0 |
| D | 2026-02-10 | 2026-02-06 | VYGR | Carter Todd Alfred | CSO | A - Grant | $0.00 | +33.0K | 156.7K | +27% | $0 |
| D | 2026-02-10 | 2026-02-06 | VYGR | Ferguson Toby | Chief Medical Off | A - Grant | $0.00 | +45.0K | 183.9K | +32% | $0 |
| D | 2026-02-10 | 2026-02-06 | VYGR | Sandrock Alfred | Pres, CEO, Dir | A - Grant | $0.00 | +86.2K | 522.2K | +20% | $0 |
| D | 2026-02-10 | 2026-02-06 | VYGR | Swartz Robin | COO, CBO | A - Grant | $0.00 | +45.0K | 214.6K | +27% | $0 |
| 2025-10-07 | 2025-10-03 | VYGR | Jorgensen Nathan D. | CFO | S - Sale | $4.78 | -7,666 | 123.8K | -6% | -$36.6K | |
| 2025-08-20 | 2025-08-18 | VYGR | Ferguson Toby | Chief Medical Off | S - Sale | $3.73 | -19.0K | 138.9K | -12% | -$70.9K | |
| 2025-04-04 | 2025-04-02 | VYGR | Ferguson Toby | Chief Medical Off | S - Sale | $3.43 | -10.1K | 157.9K | -6% | -$34.6K | |
| 2025-04-04 | 2025-04-02 | VYGR | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $3.43 | -10.9K | 430.9K | -2% | -$37.3K | |
| D | 2025-02-24 | 2025-02-20 | VYGR | Carter Todd Alfred | CSO | S - Sale | $4.26 | -3,305 | 77.7K | -4% | -$14.1K |
| D | 2025-02-24 | 2025-02-21 | VYGR | Carter Todd Alfred | CSO | A - Grant | $0.00 | +46.0K | 123.7K | +59% | $0 |
| D | 2025-02-24 | 2025-02-21 | VYGR | Swartz Robin | COO, CBO | A - Grant | $0.00 | +71.2K | 169.6K | +72% | $0 |
| D | 2025-02-24 | 2025-02-20 | VYGR | Swartz Robin | COO, CBO | S - Sale | $4.25 | -3,894 | 98.4K | -4% | -$16.5K |
| D | 2025-02-24 | 2025-02-20 | VYGR | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $4.24 | -11.7K | 296.8K | -4% | -$49.6K |
| D | 2025-02-24 | 2025-02-21 | VYGR | Sandrock Alfred | Pres, CEO, Dir | A - Grant | $0.00 | +145.0K | 441.8K | +49% | $0 |
| D | 2025-02-24 | 2025-02-21 | VYGR | Fahey Sandell Jacquelyn | CLO | A - Grant | $0.00 | +41.5K | 123.1K | +51% | $0 |
| D | 2025-02-24 | 2025-02-21 | VYGR | Ferguson Toby | Chief Medical Off | A - Grant | $0.00 | +63.0K | 168.0K | +60% | $0 |
| D | 2025-02-24 | 2025-02-21 | VYGR | Jorgensen Nathan D. | CFO | A - Grant | $0.00 | +51.5K | 131.5K | +64% | $0 |
| 2025-02-12 | 2025-02-11 | VYGR | Swartz Robin | COO, CBO | S - Sale | $4.45 | -6,950 | 102.3K | -6% | -$30.9K | |
| 2025-02-12 | 2025-02-11 | VYGR | Fahey Sandell Jacquelyn | CLO | S - Sale | $4.45 | -4,358 | 81.6K | -5% | -$19.4K | |
| 2025-02-12 | 2025-02-11 | VYGR | Carter Todd Alfred | CSO | S - Sale | $4.45 | -5,413 | 81.0K | -6% | -$24.1K | |
| 2025-02-12 | 2025-02-11 | VYGR | Sandrock Alfred | Pres, CEO | S - Sale | $4.45 | -16.6K | 308.5K | -5% | -$74.1K | |
| 2025-01-15 | 2025-01-14 | VYGR | Carter Todd Alfred | CSO | S - Sale | $5.13 | -1,191 | 86.4K | -1% | -$6,110 | |
| 2025-01-15 | 2025-01-14 | VYGR | Swartz Robin | COO, CBO | S - Sale | $5.09 | -3,087 | 109.2K | -3% | -$15.7K | |
| 2024-12-26 | 2024-12-23 | VYGR | Swartz Robin | COO, CBO | S - Sale | $5.65 | -6,500 | 112.3K | -5% | -$36.7K | |
| 2024-10-03 | 2024-10-02 | VYGR | Fahey Sandell Jacquelyn | CLO | S - Sale | $5.82 | -5,999 | 86.0K | -7% | -$34.9K | |
| 2024-10-02 | 2024-10-01 | VYGR | Jorgensen Nathan D. | CFO | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 | |
| 2024-04-03 | 2024-04-01 | VYGR | Ferguson Toby | Chief Medical Off | A - Grant | $0.00 | +105.0K | 105.0K | New | $0 | |
| 2024-04-03 | 2024-04-02 | VYGR | Swartz Robin | COO | S - Sale | $9.88 | -1,357 | 117.0K | -1% | -$13.4K | |
| 2024-04-03 | 2024-04-02 | VYGR | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $9.86 | -12.1K | 322.8K | -4% | -$119.5K | |
| 2024-02-22 | 2024-02-21 | VYGR | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $7.46 | -13.0K | 335.0K | -4% | -$97.2K | |
| 2024-02-22 | 2024-02-21 | VYGR | Swartz Robin | COO | S - Sale | $7.45 | -3,966 | 118.4K | -3% | -$29.5K | |
| M | 2024-02-22 | 2024-02-20+ | VYGR | Carter Todd Alfred | CSO | S - Sale | $7.50 | -3,967 | 91.0K | -4% | -$29.8K |
| 2024-02-22 | 2024-02-21 | VYGR | PFREUNDSCHUH PETER P. | CFO | S - Sale | $7.46 | -3,764 | 175.7K | -2% | -$28.1K | |
| D | 2024-02-16 | 2024-02-09 | VYGR | Fahey Sandell Jacquelyn | CLO | A - Grant | $0.00 | +31.0K | 92.0K | +51% | $0 |
| D | 2024-02-16 | 2024-02-09 | VYGR | Swartz Robin | COO | A - Grant | $0.00 | +50.0K | 122.3K | +69% | $0 |
| D | 2024-02-16 | 2024-02-09 | VYGR | Carter Todd Alfred | CSO | A - Grant | $0.00 | +38.5K | 91.6K | +73% | $0 |
| D | 2024-02-16 | 2024-02-09 | VYGR | Sandrock Alfred | Pres, CEO, Dir | A - Grant | $0.00 | +130.0K | 348.0K | +60% | $0 |
| D | 2024-02-16 | 2024-02-09 | VYGR | PFREUNDSCHUH PETER P. | CFO | A - Grant | $0.00 | +30.0K | 179.4K | +20% | $0 |
| 2024-01-19 | 2024-01-17 | VYGR | Carter Todd Alfred | CSO | S - Sale | $7.18 | -1,266 | 53.1K | -2% | -$9,090 | |
| 2024-01-19 | 2024-01-17 | VYGR | Swartz Robin | COO | S - Sale | $7.15 | -2,543 | 72.3K | -3% | -$18.2K | |
| 2023-10-05 | 2023-10-03 | VYGR | PFREUNDSCHUH PETER P. | CFO | S - Sale | $6.99 | -13.6K | 149.4K | -8% | -$94.8K | |
| 2023-10-02 | 2023-10-01 | VYGR | Fahey Sandell Jacquelyn | CLO | A - Grant | $0.00 | +61.0K | 61.0K | New | $0 | |
| D | 2023-09-18 | 2023-09-15 | VYGR | Carter Todd Alfred | CSO | S - Sale+OE | $8.16 | -10.5K | 54.4K | -16% | -$85.7K |
| D | 2023-09-18 | 2023-09-15 | VYGR | Carter Todd Alfred | CSO | M - OptEx | $2.85 | +5,000 | 64.9K | +8% | +$14.2K |
| 2023-07-10 | 2023-07-06 | VYGR | Carter Todd Alfred | CSO | S - Sale | $10.80 | -5,500 | 59.9K | -8% | -$59.4K | |
| D | 2023-07-05 | 2023-06-30 | VYGR | Carter Todd Alfred | CSO | M - OptEx | $2.85 | +5,000 | 70.4K | +8% | +$14.2K |
| D | 2023-07-05 | 2023-06-30 | VYGR | Carter Todd Alfred | CSO | S - Sale+OE | $11.41 | -5,000 | 65.4K | -7% | -$57.0K |
| 2023-04-05 | 2023-04-03 | VYGR | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $7.83 | -7,437 | 214.6K | -3% | -$58.2K | |
| 2023-04-05 | 2023-04-03 | VYGR | Swartz Robin | COO | S - Sale | $7.83 | -1,259 | 71.6K | -2% | -$9,858 | |
| 2023-03-22 | 2023-03-20 | VYGR | Carter Todd Alfred | CSO | S - Sale | $7.76 | -2,193 | 65.4K | -3% | -$17.0K | |
| 2023-03-22 | 2023-03-20 | VYGR | Hesslein Robert W. | GC, Senior VP | S - Sale | $7.76 | -4,410 | 102.2K | -4% | -$34.2K | |
| 2023-03-22 | 2023-03-20 | VYGR | Swartz Robin | COO | S - Sale | $7.76 | -3,654 | 72.9K | -5% | -$28.4K | |
| 2023-03-17 | 2023-03-15 | VYGR | Swartz Robin | COO | S - Sale | $8.20 | -15.4K | 76.5K | -17% | -$126.1K | |
| 2023-02-24 | 2023-02-23 | VYGR | NEUROCRINE BIOSCIENCES INC | 10% | P - Purchase | $8.88 | +4.40M | 8.58M | +105% | +$39.03M | |
| D | 2023-02-22 | 2023-02-17 | VYGR | Swartz Robin | COO | A - Grant | $0.00 | +40.0K | 91.9K | +77% | $0 |
| D | 2023-02-22 | 2023-02-17 | VYGR | Carter Todd Alfred | CSO | A - Grant | $0.00 | +34.0K | 68.3K | +99% | $0 |
| D | 2023-02-22 | 2023-02-17 | VYGR | Carter Todd Alfred | CSO | S - Sale | $7.45 | -738 | 67.6K | -1% | -$5,498 |
| 2023-02-22 | 2023-02-17 | VYGR | Hesslein Robert W. | GC, Senior VP | S - Sale | $7.45 | -3,297 | 106.6K | -3% | -$24.6K | |
| D | 2023-02-22 | 2023-02-17 | VYGR | PFREUNDSCHUH PETER P. | CFO | A - Grant | $0.00 | +38.0K | 163.0K | +30% | $0 |
| D | 2023-02-22 | 2023-02-17 | VYGR | Sandrock Alfred | Pres, CEO, Dir | A - Grant | $0.00 | +120.0K | 222.1K | +118% | $0 |
| 2023-02-15 | 2023-02-13 | VYGR | Hesslein Robert W. | GC, Senior VP | S - Sale | $7.67 | -2,868 | 109.9K | -3% | -$22.0K | |
| 2023-02-15 | 2023-02-13 | VYGR | Carter Todd Alfred | CSO | S - Sale | $7.67 | -797 | 34.3K | -2% | -$6,113 | |
| 2023-02-06 | 2023-02-02 | VYGR | Third Rock Ventures III, L.P. | 10% | J - Other | — | -1.50M | 3.19M | -32% | — | |
| M | 2023-02-01 | 2023-01-30+ | VYGR | Third Rock Ventures III, L.P. | 10% | S - Sale | $9.23 | -388.6K | 5.00M | -7% | -$3.59M |
| 2023-01-31 | 2023-01-27 | VYGR | TEPPER ROBERT I | 10% | S - Sale | $9.02 | -50.0K | 5.07M | -1.0% | -$451.0K | |
| M | 2023-01-26 | 2023-01-24+ | VYGR | Third Rock Ventures III, L.P. | 10% | S - Sale | $9.25 | -150.0K | 5.12M | -3% | -$1.39M |
| M | 2023-01-24 | 2023-01-20+ | VYGR | Third Rock Ventures GP III, L.P. | 10% | S - Sale | $9.12 | -155.0K | 5.27M | -3% | -$1.41M |
| M | 2023-01-19 | 2023-01-17 | VYGR | Hesslein Robert W. | GC, Senior VP | S - Sale | $9.85 | -2,188 | 113.6K | -2% | -$21.5K |
| M | 2023-01-19 | 2023-01-17 | VYGR | Swartz Robin | COO | S - Sale | $9.85 | -2,188 | 51.9K | -4% | -$21.5K |
| M | 2023-01-19 | 2023-01-17 | VYGR | Carter Todd Alfred | CSO | S - Sale | $9.85 | -1,106 | 35.1K | -3% | -$10.9K |
| MI | 2023-01-11 | 2023-01-09+ | VYGR | EcoR1 Capital, LLC | 10% | S - Sale | $7.91 | -902.4K | 3.96M | -19% | -$7.14M |
| 2023-01-10 | 2022-12-31 | VYGR | Carter Todd Alfred | CSO | A - Grant | $5.17 | +388 | 36.6K | +1% | +$2,006 | |
| 2023-01-10 | 2023-01-06 | VYGR | Carter Todd Alfred | CSO | S - Sale | $6.41 | -388 | 36.2K | -1% | -$2,487 | |
| 2022-10-04 | 2022-10-01 | VYGR | PFREUNDSCHUH PETER P. | CFO | A - Grant | $0.00 | +125.0K | 125.0K | New | $0 | |
| M | 2022-08-26 | 2022-08-24+ | VYGR | Third Rock Ventures GP III, L.P. | 10% | S - Sale | $6.16 | -350.0K | 5.43M | -6% | -$2.16M |
| 2022-08-18 | 2022-08-16 | VYGR | Third Rock Ventures GP III, L.P. | 10% | S - Sale | $6.04 | -128.5K | 5.78M | -2% | -$775.9K | |
| M | 2022-08-16 | 2022-08-12+ | VYGR | Third Rock Ventures GP III, L.P. | 10% | S - Sale | $6.10 | -483.8K | 6.04M | -7% | -$2.95M |
| 2022-07-18 | 2022-07-14 | VYGR | PIERCE GLENN | Dir | S - Sale | $6.70 | -9,512 | 16.8K | -36% | -$63.7K | |
| 2022-07-18 | 2022-07-14 | VYGR | Higgins Michael J | Dir | S - Sale | $6.70 | -13.9K | 31.3K | -31% | -$93.1K | |
| MI | 2022-06-23 | 2022-06-21+ | VYGR | EcoR1 Capital, LLC | 10% | P - Purchase | $5.58 | +477.4K | 4.75M | +11% | +$2.66M |
| 2022-04-06 | 2022-04-04 | VYGR | Swartz Robin | COO | S - Sale | $8.25 | -1,527 | 52.1K | -3% | -$12.6K | |
| 2022-04-06 | 2022-04-04 | VYGR | Hesslein Robert W. | GC, Senior VP | S - Sale | $8.25 | -2,786 | 115.0K | -2% | -$23.0K | |
| D | 2022-03-23 | 2022-03-22 | VYGR | Sandrock Alfred | Pres, CEO, Dir | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
| M | 2022-03-23 | 2022-03-21 | VYGR | Hesslein Robert W. | GC, Senior VP | S - Sale | $8.29 | -4,955 | 117.8K | -4% | -$41.1K |
| M | 2022-03-23 | 2022-03-21 | VYGR | Burek Julie | VP, Fin | S - Sale | $8.29 | -2,649 | 52.5K | -5% | -$22.0K |
| M | 2022-03-23 | 2022-03-21 | VYGR | Swartz Robin | COO | S - Sale | $8.29 | -4,413 | 53.6K | -8% | -$36.6K |
| 2022-02-22 | 2022-02-17 | VYGR | Burek Julie | VP, Fin | S - Sale | $3.55 | -789 | 55.1K | -1% | -$2,801 |
Purchase Sale Sale after option exercise All abbreviations